Cowen Downgrades Celldex Therapeutics (CLDX) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) | Delayed: 28.96 -0.01 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.97 | 52 Week High | $18.62 | |||
| Open | $28.95 | 52 Week Low | $2.85 | |||
| Day High | $29.13 | P/E | N/A | |||
| Day Low | $28.20 | EPS | $-1.02 | |||
| Volume | 383,382 | |||||
